Skip to content

Clinical trials

Terminated Phase 2 Endometrial Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Endometrial Neoplasms Phase: Phase 2 Status: Terminated Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20091
20103
20121
20141
20172
20191
20202
20213
20224
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated24

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center3
Gynecologic Oncology Group2
Artios Pharma Ltd1
Cancer Trials Ireland1
Columbia University1
Donna Hammond, PhD1
Fox Chase Cancer Center1
Henry Ford Health System1
Ipsen1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Endometrial Neoplasms24
Neoplasm Metastasis6
Ovarian Neoplasms4
Recurrence4
Colonic Neoplasms3
Uterine Cervical Neoplasms3
Breast Neoplasms2
Esophageal Neoplasms2
Fallopian Tube Neoplasms2
Head and Neck Neoplasms2

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.